Repligen Stock Forward View - Simple Regression
| RGEN Stock | USD 124.07 4.08 3.40% |
Momentum 34
Sell Stretched
Oversold | Overbought |
Hype-based context for Repligen connects recent headlines with price response and peer activity.
The Simple Regression forecasted value of Repligen on the next trading day is expected to be 128.73 with a mean absolute deviation of 6.40 and the sum of the absolute errors of 390.10.Repligen after-hype prediction price | USD 119.99 |
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
Use Historical Fundamental Analysis of Repligen to cross-verify projections for Repligen. The historical series provides projection context.To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Repligen Additional Predictive Modules
Most predictive techniques to examine Repligen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Repligen using various technical indicators. When you analyze Repligen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Repligen Simple Regression Price Forecast For the 10th of March
Given 90 days horizon, the Simple Regression forecasted value of Repligen on the next trading day is expected to be 128.73 with a mean absolute deviation of 6.40 , mean absolute percentage error of 61.52 , and the sum of the absolute errors of 390.10 .Please note that although there have been many attempts to predict Repligen Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Repligen's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Repligen Stock Forecast Pattern
| Backtest Repligen | Repligen Price Prediction | Research Analysis |
Repligen Forecasted Value
This next-day forecast for Repligen uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Repligen stock data series using in forecasting. Note that when a statistical model is used to represent Repligen stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.2298 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 6.395 |
| MAPE | Mean absolute percentage error | 0.0416 |
| SAE | Sum of the absolute errors | 390.098 |
Mean reversion in Repligen's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Repligen After-Hype Price Density Analysis
Understanding Repligen's probability distribution helps investors calibrate position size to their risk tolerance. The tails of the Repligen distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
Next price density |
| Expected price to next headline |
Repligen Estimiated After-Hype Price Volatility
Using Repligen's historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. Repligen's after-hype downside and upside margins for the prediction period are 117.98 and 122.00, respectively. Note that past news reactions for Repligen are not guaranteed to repeat, particularly in novel market environments.
Current Value
The after-hype framework applied to Repligen assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Repligen Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Repligen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Repligen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Repligen, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.46 | 2.01 | 0.00 | 0.10 | 0 Events | 1 Events | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
124.07 | 119.99 | 0.00 |
|
Repligen Hype Timeline
Repligen is at this time traded for 124.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.1. Repligen is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.46%. %. The volatility of related hype on Repligen is about 962.23%, with the expected price after the next announcement by competition of 124.17. About 95.0% of the company shares are owned by institutional investors. The book value of Repligen was at this time reported as 37.39. The company has Price/Earnings (P/E) ratio of 154.58. Repligen last dividend was issued on the 29th of October 2010. Given the investment horizon of 90 days the next forecasted press release will be within a week. Use Historical Fundamental Analysis of Repligen to cross-verify projections for Repligen. The historical series provides projection context.To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Repligen Related Hype Analysis
Understanding how Repligen's direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect Repligen's performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AVTR | Avantor | 0.00 | 0 per month | 0.00 | -0.14 | 3.20 | -4.11 | 21.90 | |
| MASI | Masimo | 0.00 | 0 per month | 1.26 | 0.1 | 2.82 | -2.11 | 34.38 | |
| BAX | Baxter International | 0.00 | 0 per month | 3.69 | -0.0006 | 4.80 | -3.63 | 21.62 | |
| ATR | AptarGroup | 3.15 | 3 per month | 1.14 | 0.13 | 2.93 | -1.97 | 10.37 | |
| BIO | Bio Rad Laboratories | 0.00 | 0 per month | 0.00 | -0.09 | 2.26 | -2.65 | 17.86 | |
| DVA | DaVita HealthCare Partners | 0.00 | 0 per month | 1.65 | 0.14 | 3.95 | -3.13 | 26.79 | |
| CRL | Charles River Laboratories | 0.00 | 0 per month | 0.00 | -0.03 | 3.93 | -4.36 | 13.65 | |
| GMED | Globus Medical | 0.00 | 0 per month | 0.00 | -0.01 | 3.12 | -2.45 | 7.42 | |
| STVN | Stevanato Group SpA | -1.27 | 8 per month | 0.00 | -0.13 | 4.36 | -5.95 | 27.89 |
Other Forecasting Options for Repligen
The price movement of Repligen is a central concern for all potential investors, regardless of their level of expertise. Repligen Stock price charts can be difficult to interpret due to the noise present in the data.Repligen Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Repligen stock to make a market-neutral strategy. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Repligen Market Strength Events
Market strength indicators applied to Repligen stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell Repligen.
Repligen Risk Indicators
Risk indicator analysis for Repligen's is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in Repligen's investment, investors can make informed decisions about position sizing and risk mitigation.
| Mean Deviation | 1.58 | |||
| Standard Deviation | 2.01 | |||
| Variance | 4.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Repligen
Coverage intensity for Repligen matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Repligen Short Properties
Short sentiment tied to Repligen matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 56.6 M | |
| Cash And Short Term Investments | 767.6 M |
More Resources for Repligen Stock Analysis
A structured review of Repligen often starts with core financial statements and trend context. Ratios and trend metrics help frame Repligen's operating context. Key reports that frame Repligen Stock are listed below:Use Historical Fundamental Analysis of Repligen to cross-verify projections for Repligen. The historical series provides projection context.To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Analysis related to Repligen should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
The market value of Repligen is measured differently than book value, which reflects Repligen accounting equity. Intrinsic value is an analytical estimate of Repligen's underlying worth that can differ from price and book value. Prices respond to market conditions and behavior, which can widen gaps versus fundamentals. Valuation methods help interpret those gaps.
Note that Repligen's intrinsic value and market price are different measures derived from different inputs. A full view may include fundamental ratios, momentum patterns, industry dynamics, and analyst estimates. Market price reflects the current exchange level formed by active bids and offers.